Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
Cintas Terminates Discussions with UniFirst
-
Paragon 28 to Showcase Recent Product Launches at The American College of Foot and Ankle Surgeons Annual Conference
-
Quince Therapeutics Provides Business Update and Reports Fiscal Year 2024 Financial Results
-
Columbus McKinnon Declares Quarterly Dividend of $0.07 per Share
-
Albertsons Companies Announces Fourth Quarter and Fiscal 2024 Earnings Release and Conference Call Date
-
Vicarious Surgical Announces President Transition to Board Member Role
-
Oklo Publishes Full Year 2024 Financial Results and Business Update
-
Capital One Financial Corporation to Webcast Conference Call on First Quarter 2025 Earnings
-
NEXGEL Reports Record Fourth Quarter and Full Year 2024 Financial Results
-
Nasdaq to Hold First Quarter 2025 Investor Conference Call
-
Dragonfly Energy Reports Fourth Quarter and Full Year 2024 Results
-
MODV DEADLINE: ROSEN, A TOP RANKED LAW FIRM, Encourages ModivCare Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - MODV
-
OrthoPediatrics Corp. Named One the 2025 Best Places to Work in Indiana
-
Artiva Biotherapeutics Reports Full Year 2024 Financial Results and Recent Business Highlights
-
Option Care Health to Announce First Quarter 2025 Financial Results and Host Conference Call
-
Skookum Transitions to Tessera, Strengthening Commitment to Excellence and Inclusion
-
Prairie Operating Co. Announces Public Offering of Common Stock
-
MiLi MiTag Duo - The World’s First Apple and Google Licensed Bluetooth Tracker in One Device
-
Oklo Appoints Two New Board Members Following Chris Wright’s Confirmation as U.S. Secretary of Energy
-
Montréal Exchange President and CEO Luc Fortin to Present at the 23rd Annual National Bank Financial Services Conference
-
PPTA INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Perpetua Resources Corp. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
-
ZYXI INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Zynex, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
-
SWKS INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Skyworks Solutions, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
-
MANH INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Manhattan Associates, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
-
TTD INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that The Trade Desk, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
-
ALAR INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Alarum Technologies Ltd. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
-
FMC INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that FMC Corporation Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
-
NEM INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Newmont Corporation Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
-
TGT INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Target Corporation Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
-
FINAL REMINDER EPIX DEADLINE: Bronstein, Gewirtz & Grossman LLC Alerts ESSA Pharma Inc. Investors to Participate in the Class Action Lawsuit!
-
FINAL REMINDER NVO DEADLINE: Bronstein, Gewirtz & Grossman LLC Alerts Novo Nordisk A/S Investors to Participate in the Class Action Lawsuit!
-
FINAL REMINDER CROX DEADLINE: Bronstein, Gewirtz & Grossman LLC Alerts Crocs, Inc. Investors to Participate in the Class Action Lawsuit
-
Acutus Medical Reports Full Year 2024 Financial Results
-
SKYX Reports 48% Revenue Growth in 2024 — From $58.8 Million in 2023 to $86.3 Million in 2024
-
13.4% Stake Acquired by Another Institutional Investor in ConnectM, Bringing Total Institutional Ownership to 46.4%
-
Aura Biosciences Reports Fourth Quarter and Full Year 2024 Financial Results and Business Highlights
-
MindMed Announces New Employee Inducement Grants
-
Omnicell Welcomes Perry A. Genova, PhD, as Chief Technology Officer
-
Delcath Systems to Participate at the Canaccord Genuity Horizons in Oncology Virtual Conference
-
PrairieSky Royalty Announces Conference Call for Q1 2025 Results
-
SolarBank Corporation Announces Closing of up to US$19 Million Equity Financing
-
Inland Empire Health Plan earns 22 American Advertising Awards
-
The Brattle Group Expands Its Commercial Litigation and Regulatory Expertise in Sydney with the Addition of Hans Weemaes
-
Leonardo DRS Celebrates Delivery of 100,000th Mission Critical Combat Computing System to the U.S. Army
-
Semtech CEO to Share Market Vision at Optica Executive Forum
-
NYSE to Commence Delisting Proceedings with Respect to Warrants of E2open Parent Holdings, Inc. (ETWO-WT)
-
Over One-Fifth of Native North American Pollinators at Elevated Risk of Extinction
-
Michael Terpin Joins Lendr.fi as Key Advisor to Transform RWA Tokenization
-
Samsara ($SAMS) Unveils AI-Powered Workforce Automation on the Blockchain
-
Marex Group plc Provides Details for Upcoming Investor Day on April 2, 2025
